{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:08:11Z","timestamp":1773796091143,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.rmed.2024.107835","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:21:03Z","timestamp":1729257663000},"page":"107835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-0436","authenticated-orcid":false,"given":"Bathmapriya","family":"Balakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5966-152X","authenticated-orcid":false,"given":"Jehad","family":"Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Farha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1785-4032","authenticated-orcid":false,"given":"Alice M.","family":"Goyanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3666-7424","authenticated-orcid":false,"given":"Deborah","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin B.","family":"Highland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-6202","authenticated-orcid":false,"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano R.","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2024.107835_bib1","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"European Respiratory Journal [Internet]"},{"issue":"1","key":"10.1016\/j.rmed.2024.107835_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.athoracsur.2015.06.024","article-title":"Influence of pulmonary hypertension on patients with idiopathic pulmonary fibrosis awaiting lung transplantation","volume":"101","author":"Hayes","year":"2016","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.rmed.2024.107835_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review","volume":"46","author":"Raghu","year":"2015","journal-title":"European Respiratory Journal [Internet]"},{"issue":"4","key":"10.1016\/j.rmed.2024.107835_bib4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.chest.2020.04.046","article-title":"The trouble with group 3 pulmonary hypertension in interstitial lung disease","volume":"158","author":"King","year":"2020","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2024.107835_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"New England Journal of Medicine [Internet]"},{"issue":"2","key":"10.1016\/j.rmed.2024.107835_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1164\/rccm.202107-1766OC","article-title":"Efficacy of inhaled treprostinil on multiple disease progression events in patients with pulmonary hypertension due to parenchymal lung disease in the INCREASE trial","volume":"205","author":"Nathan","year":"2022","journal-title":"Am J Respir Crit Care Med [Internet]"},{"issue":"6","key":"10.1016\/j.rmed.2024.107835_bib7","article-title":"Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study","volume":"61","author":"Waxman","year":"2023","journal-title":"European Respiratory Journal [Internet]"},{"key":"10.1016\/j.rmed.2024.107835_bib8","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/j.jval.2021.04.1003","article-title":"PRO18 A systematic literature review of the economic burden and cost drivers in pulmonary arterial hypertension","volume":"24","author":"Phatak","year":"2021","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.rmed.2024.107835_bib9","article-title":"Real\u2010world use of inhaled treprostinil for lung disease\u2010pulmonary hypertension: a protocol for patient evaluation and prescribing","volume":"12","author":"Johnson","year":"2022","journal-title":"Pulm Circ [Internet]"},{"issue":"7624","key":"10.1016\/j.rmed.2024.107835_bib10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Elm","year":"2007","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.rmed.2024.107835_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"European Respiratory Journal [Internet]"},{"issue":"150","key":"10.1016\/j.rmed.2024.107835_bib12","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"European Respiratory Review [Internet]"},{"issue":"9","key":"10.1016\/j.rmed.2024.107835_bib13","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med [Internet]"},{"issue":"6","key":"10.1016\/j.rmed.2024.107835_bib14","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1111\/1755-5922.12050","article-title":"Geometry of the randomized evidence for treatments of pulmonary hypertension","volume":"31","author":"Tonelli","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.rmed.2024.107835_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2024.107835_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00150314","article-title":"An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease","volume":"44","author":"Holland","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2024.107835_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"4","key":"10.1016\/j.rmed.2024.107835_bib18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3949\/ccjm.83a.14186","article-title":"What is the best approach to a high systolic pulmonary artery pressure on echocardiography?","volume":"83","author":"Ahmed","year":"2016","journal-title":"Cleve. Clin. J. Med."},{"issue":"8","key":"10.1016\/j.rmed.2024.107835_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2010.02.005","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Schulz","year":"2010","journal-title":"J. Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.rmed.2024.107835_bib20","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1164\/rccm.202208-1547OC","article-title":"Minimal clinically important difference in the 6-minute-walk distance for patients with pulmonary arterial hypertension","volume":"207","author":"Moutchia","year":"2023","journal-title":"Am J Respir Crit Care Med [Internet]"},{"issue":"1","key":"10.1016\/j.rmed.2024.107835_bib21","first-page":"55","article-title":"Comprehensive exercise capacity and quality of life assessments predict mortality in patients with pulmonary arterial hypertension","volume":"35","author":"Chen","year":"2019","journal-title":"Acta Cardiol Sin [Internet]"},{"issue":"10","key":"10.1016\/j.rmed.2024.107835_bib22","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/CIRCRESAHA.117.311737","article-title":"PVDOMICS: a multi-center study to improve understanding of pulmonary vascular disease through phenomics","volume":"121","author":"Hemnes","year":"2017","journal-title":"Circ Res [Internet]"},{"issue":"1","key":"10.1016\/j.rmed.2024.107835_bib23","article-title":"Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis","volume":"9","author":"Nathan","year":"2022","journal-title":"BMJ Open Respir Res [Internet]"},{"key":"10.1016\/j.rmed.2024.107835_bib24","series-title":"B48 NEW TREATMENTS IN DIFFUSE PARENCHYMAL LUNG DISEASE","article-title":"Study design and rationale for the TETON-PPF clinical trial of inhaled treprostinil for the treatment of progressive pulmonary fibrosis","author":"Nathan","year":"2024"},{"issue":"22","key":"10.1016\/j.rmed.2024.107835_bib25","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.rmed.2024.107835_bib26","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107835_bib27","series-title":"1301 - Pulmonary Hypertension","first-page":"2133","article-title":"Inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease: event-free survival in INCREASE study open-label extension","author":"Nathan","year":"2022"},{"issue":"1","key":"10.1016\/j.rmed.2024.107835_bib28","article-title":"Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study","volume":"11","author":"Weatherald","year":"2024","journal-title":"BMJ Open Respir Res [Internet]"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112400310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112400310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T22:34:06Z","timestamp":1732314846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112400310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"alternative-id":["S095461112400310X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107835","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107835"}}